Synthetic Genomics Inc.

Industry

  • Biotechnology
    • Transgenics
    • Drug Discovery Technologies
      • Genomics-Proteomics
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
See more in Biomedtracker

Latest on Synthetic Genomics Inc.

Scrip

Venter's Synthetic Genomics Sued For Gender Discrimination

 
• By Mandy Jackson

Teresa Spehar, former vice president of intellectual property at Synthetic Genomics Inc. , has sued the company for gender discrimination against herself and other women working for the San Diego,

Scrip

Appointments: Sanofi, Regeneron, Galena, Genmab, Abpro and Myokardia

 
• By Lubna Ahmed

Sanofi has appointed Kathleen Tregoning a member of its executive committee and executive vice president, external affairs – effective Feb. 27, 2017. Tregoning joins Sanofi from Biogen Inc.

In Vivo

Synthetic Biology And The Computerization Of Drug Development

 
• By Melanie Senior

Over the last three decades, digital technologies have transformed lifestyles, livelihoods and businesses, creating new wealth, industrial sectors and opportunities. The impact of synthetic biology –

In Vivo

Execs On The Move, December 2014

New At The Helm Company Changes AHUJA , Sanjeev, MD To: Celtaxsys Inc. , CMO (November) From: On Target Laboratories, CMO Phone: 415-829-7110 BAGAI , Shaun R. To: RenovoRx Inc. , CEO (Octo